Sort by:
659 products
659 products
METRIGEN FUERTE 5MG/50MG INJECTABLE SOLUTION
Comparable to: Gestrygen
Active ingredient: Progesterone, Estradiol Benzoate
Concentration: 5mg/50mg
Presentation: Injectable solution
Laboratory: ASPEN LABS
Origin: Made in Mexico
Metrigen Fuerte is an injectable solution used for certain gynecological conditions or to regulate the menstrual cycle. Its specific formulation acts on the female hormonal system, helping to alleviate symptoms and restore balance. It must be administered under strict medical supervision.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MEVEDIM (DIOSMIN) 600MG 30 TABLETS
Comparable to: Daflon
Active ingredient: Diosmin
Concentration: 600mg
Presentation: 30 tablets
Laboratory: WERMAR
Origin: Made in Mexico
Medication containing Diosmin, a phlebotonic used to improve venous tone and protect blood vessels. It is indicated in the treatment of chronic venous insufficiency, varicose veins, edema, and hemorrhoids, relieving symptoms such as heavy legs, pain, and cramps.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
MEXAPIN SUSP 60 ML 500 MG
Comparable to: Pentrexyl
Active ingredient: AMOXICILLIN
Concentration: 500 mg / 5 ml
Presentation: ORAL SUSPENSION
Laboratory: MEXAPIN
Origin: Made in Mexico
Mexapin is a broad-spectrum antibiotic based on Amoxicillin 500 mg, indicated for the treatment of bacterial infections of the respiratory and urinary tracts, skin, and soft tissues. Its oral suspension presentation facilitates administration in pediatric patients and adults who have difficulty swallowing tablets. Each bottle contains 60 ml ready for reconstitution.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication. Its sale requires a prescription.
MICARDIS (TELMISARTAN) 40 mg 28 TAB
Comparable to: Generic Telmisartan
Active substance: Telmisartan
Concentration: 40 mg
Presentation: Tablets
Laboratory: Boehringer Ingelheim
Origin: Mexico
This medication is used for the treatment of arterial hypertension (high blood pressure). Telmisartan is an angiotensin II receptor blocker (ARB) that works by relaxing and widening blood vessels, which helps to lower blood pressure and reduce the workload on the heart. As indicated by a doctor, it can also be used to reduce the risk of cardiovascular events in patients with selected risk factors.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MICARDIS (TELMISARTAN) 80 mg 28 TAB
Comparable to: Generic Telmisartan
Active substance: Telmisartan
Concentration: 80 mg
Presentation: Tablets
Laboratory: Boehringer Ingelheim
Origin: Mexico
This medication is primarily used for the treatment of arterial hypertension (high blood pressure). Telmisartan is an angiotensin II receptor blocker (ARB) that works by relaxing and widening blood vessels, which helps reduce blood pressure and decrease the heart's workload. It can also be used to reduce the risk of cardiovascular events in patients with selected risk factors, as directed by a doctor.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
CONTRAINDICATIONS: Hypersensitivity to any of the ingredients. During pregnancy and lactation. In patients with obstructive disease of the bile ducts and severe hepatic failure.
CAUTIONS:
Renovascular hypertension: Risk of severe hypotension and renal insufficiency when patients with bilateral stenosis of renal artery stenosis or artery of a functioning kidney are treated with drugs affecting the renin-angiotensin-aldosterone system.
Renal failure and kidney transplantation: MICARDIS * When given to patients with renal insufficiency is recommended continued monitoring of plasma potassium and creatinine. There is no experience with the drug's use in patients with recent kidney transplant.
Intravascular volume depletion, can occur manifestations symptomatic hypotension, especially after the first dose administration in patients with volume depletion and / or sodium after extensive treatment with diuretics in salt-restricted diets, diarrhea or vomiting. These conditions, especially volume depletion and / or sodium should be corrected prior to administration of MICARDIS *.
Other conditions with stimulation of the renin-angiotensin-aldosterone system: In patients whose vascular tone and renal function depend predominantly on the activity of the renin-angiotensin-aldosterone system (eg patients with severe congestive heart failure or underlying renal disease, including renal artery stenosis), treatment with drugs that affect this system has been associated with acute hypotension, azotemia, oliguria, and rarely with acute renal failure.
Primary aldosteronism: patients with primary aldosteronism generally will not respond to antihypertensive treatments that act by inhibiting the renin-angiotensin system, so this medication is not recommended in these cases.
Aortic and mitral stenosis, hypertrophic obstructive cardiomyopathy: As with other vasodilators, special caution is recommended in patients with these diseases.
Hyperkalemia: Hyperkalemia may occur during treatment with drugs that affect the renin-angiotensin-aldosterone system, especially in cases of renal failure and / or heart disease. It is advisable to monitor serum potassium in patients at risk.
Based on experience with drugs affecting the renin-angiotensin-aldosterone system, concomitant use of potassium-sparing diuretics, potassium supplements, salt substitutes containing potassium or other drugs that increase potassium levels (heparin, etc.) can lead to an increase in serum potassium levels, so caution should be exercised when administered simultaneously with MICARDIS *.
Hepatic impairment: The drug is eliminated with the bile. In patients with obstructive disease of the bile ducts or liver failure is expected to have decreased their disposal. MICARDIS * should be used with caution in these patients.
Sorbitol: A daily dose of 40 mg of MICARDIS *, which contains 169 mg of sorbitol, or 80 mg to 338 mg, are not suitable for patients with hereditary fructose intolerance.
Other: As with other ACE inhibitors, angiotensin receptor blockers, including MICARDIS *, are apparently less effective in lowering blood pressure in black hypertensive patients, probably due to the high prevalence of stages with concentrations low renin.
As with other antihypertensive therapy, excessive lowering of blood pressure in patients with ischemic heart disease can result in a myocardial infarction or cerebral vascular disease (CVD).
There have been no studies on the ability to manage vehicles and equipment, but must take into account that dizziness or drowsiness may occur as a result of antihypertensive therapy.
RESTRICTIONS OF USE DURING PREGNANCY AND LACTATION: MICARDIS * should not be administered during pregnancy and lactation. We should make a change to a suitable alternative if you are planning a pregnancy.
During pregnancy, substances that act directly on the renin-angiotensin system can cause injury and even death to product development, therefore, telmisartan is contraindicated during pregnancy.
If it is determined during medication pregnancy with telmisartan, the latter should be discontinued immediately.
The recommended dose is 40 to 80 mg once a day. Some patients may benefit from a dose of 20 mg. In cases where failure to obtain the expected decline in blood pressure, may be increased to 80 mg a day.
When considering an increase in dosage should be noted that the maximum antihypertensive effect is usually obtained after 4 to 8 weeks after starting treatment.
In patients with severe hypertension have used dosages higher than 160 mg alone or in combination with 12.5 to 25 mg of hydrochlorothiazide daily, they have been effective and welltolerated.
No dose adjustment is necessary in patients with renal impairment, including hemodialysis.The drug is not withdrawn from circulation by hemofiltration. In patients with hepatic impairment or moderate, the maximum recommended daily dose is 40 mg. In elderly subjectsis not necessary dosage adjustments.
No information on the safety and efficacy of MICARDIS * in children and adolescents.
MICARDIS * can be administered before or after food.
MICARDIS
Comparable to: Telmisartan
Active substance: Telmisartan
Concentration: 40MG
Presentation: 14 TABS
Laboratory: BOEHRINGER INGELHEIM
Origin: Made in Mexico
Telmisartan is an angiotensin II receptor blocker (ARB-II) that relaxes blood vessels, helping to reduce blood pressure. It is prescribed for high blood pressure and to reduce cardiovascular risk in high-risk patients.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.
MICARDIS PLUS
Comparable to: Aurax
Active ingredient: Telmisartan / Hydrochlorothiazide
Concentration: 80MG/12.5MG
Presentation: 28 TABS
Laboratory: BOEHRINGER INGELHEIM
Origin: Made in Mexico
The combination of Telmisartan (ARB) and Hydrochlorothiazide (diuretic) is used to treat hypertension. Telmisartan relaxes blood vessels and HCTZ reduces fluid volume, providing dual control to lower blood pressure.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before consuming any medication.
MICARDIS PLUS 14 TAB
Comparable to: Generic Telmisartan / Hydrochlorothiazide
Active ingredient: Telmisartan / Hydrochlorothiazide
Strength: Typical example 80 mg / 12.5 mg (also available as 80 mg / 25 mg)
Presentation: Tablets box with 14
Laboratory: Boehringer Ingelheim
Origin: Mexico
This medication is used for the treatment of essential hypertension, especially in patients whose blood pressure is not adequately controlled with a single antihypertensive. Telmisartan is an angiotensin II receptor antagonist that helps relax and widen blood vessels, and hydrochlorothiazide is a thiazide diuretic that reduces fluid retention and blood pressure. The combination of both contributes to more effective blood pressure control.
The use of this product is the responsibility of the person who recommends it and the person who uses it. Consult your doctor before consuming any medication.
Mycostatin (Nystatin) 10,000,000 IU
Active ingredient: Nystatin
Concentration: 10,000,000 IU
Presentation: Pediatric drops
Laboratory: Bristol Myers Squibb
Origin: Made in Mexico
This medication is an oral antifungal in drops indicated for the treatment of oral candidiasis (thrush) and fungal infections of the digestive tract in infants and children. It works by adhering to the fungal membrane to destroy it and relieve symptoms such as white patches in the mouth and difficulty feeding.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
Mycostatin (Nystatin) 100,000 IU
Active substance: Nystatin
Concentration: 100,000 IU per dose
Presentation: Pediatric suspension
Laboratory: Bristol Myers Squibb
Origin: Made in Mexico
This medication is an oral antifungal suspension indicated for the treatment of oral candidiasis (thrush) and fungal infections in the gastrointestinal tract of infants and children. It acts directly on the fungus without being significantly absorbed into the body.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MICROGYNON “CD” (LEVONORGESTREL / ETHINYL ESTRADIOL) 28 DRAGEES
Comparable to: Generic Levonorgestrel / Ethinyl Estradiol
Active substance: Levonorgestrel / Ethinyl Estradiol
Concentration: 150 µg / 30 µg
Presentation: Dragees
Laboratory: Bayer
Origin: Mexico
This medication is used as a combined oral contraceptive for the prevention of pregnancy. It works by inhibiting ovulation, modifying cervical mucus to hinder sperm passage, and altering the endometrium, reducing the possibility of implantation. It can also help regulate the menstrual cycle and decrease menstrual bleeding and pain.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MICROGYNON (ETHINYL ESTRADIOL / LEVONORGESTREL) C/21 TAB
Comparable to: Generic Ethinyl Estradiol / Levonorgestrel
Active substance: Ethinyl Estradiol / Levonorgestrel
Concentration: 30 µg / 150 µg
Presentation: Tablets
Laboratory: Bayer
Origin: Mexico
This medication is used as a combined oral contraceptive for pregnancy prevention. Its mechanism of action involves inhibiting ovulation, thickening cervical mucus to hinder sperm passage, and modifying the endometrium, reducing the likelihood of implantation. It can also help regulate the menstrual cycle and decrease bleeding and pain associated with menstruation.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
MICROLAX 90 mg - 9 mg/mL MICROENEMAS
Active ingredient: Sodium Citrate / Sodium Lauryl Sulfoacetate / Sorbitol
Concentration: 90 mg - 9 mg/mL
Presentation: Box with 4 microenemas of 5 mL
Laboratory: JOHNSON & JOHNSON
Origin: Made in Mexico
Microlax is a fast-acting rectal laxative in microenema form, indicated for the relief of occasional constipation. Its formula acts locally in the rectum, softening the stool and facilitating its evacuation gently and effectively. It generally produces an effect within 5 to 15 minutes after application. Its practical 5 mL microenema presentation facilitates its use and dosage.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
MICTASOL 400 mg/100 mg
Comparable to: Urobacid
Active ingredient: Norfloxacin / Phenazopyridine
Concentration: 400 mg / 100 mg per tablet
Presentation: Box with 16 tablets
Laboratory:
Origin: Made in Mexico
This medication combines a fluoroquinolone antibiotic (norfloxacin) with a urinary analgesic (phenazopyridine) for the treatment of urinary tract infections such as cystitis and urethritis caused by microorganisms sensitive to norfloxacin. Norfloxacin eliminates the bacterial infection while phenazopyridine rapidly relieves symptoms of burning, pain, and urinary urgency.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>